Video

Dr. Yao on Transplants Beyond Milan Criteria for Liver Cancer

Author(s):

Francis Yao, MD, gastroenterologist and medical director of the Liver Transplant Program at the University of California San Francisco Medical Center, discusses liver transplants beyond Milan criteria for patients with liver cancer.

Francis Yao, MD, gastroenterologist and medical director of the Liver Transplant Program at the University of California San Francisco Medical Center, discusses liver transplants beyond Milan criteria for patients with liver cancer.

Over the past 20 years, physicians' knowledge of liver transplants for patients with liver cancer has increased, explains Yao. In 1996, the Milan criteria was published, suggesting that transplanting in early stages of liver cancer is the best way to achieve positive results. The Milan criteria is one single lesion up to 5 centimeters, or 2 to 3 lesions up to 3 centimeters.

The Milan criteria has been questioned over the past couple of years, according to Yao. There have been some cases where patients have been outside of the Milan criteria and responded positively to the transplant treatment.

Related Videos
Armin Ghobadi, MD, professor, medicine, Oncology, Section of Bone Marrow Transplant; clinical director, Center for Gene and Cellular Immunotherapy, Siteman Cancer Center, Washington University
Timothy S. Fenske, MD, MS
Roxana S. Dronca, MD, discusses the FDA’s approval of subcutaneous nivolumab across solid tumor indications.
Craig Eckfeldt, MD
Whitney Goldsberry, MD
Jonathan Wesley Riess, MD, MS, an associate professor at the University of California (UC) Davis
Yair Lotan, MD, professor, urology, chief, urologic oncology, Jane and John Justin Distinguished Chair in Urology, UT Southwestern Harold C. Simmons Comprehensive Cancer Center; medical director, Urology Clinic, UT Southwestern and Parkland Health and Hospital System
Laura A. Huppert, MD
Polly Niravath, MD
Arvind N. Dasari, MD, MS